Absci is harnessing AI to design drug candidates for previously undruggable targets, unlocking new biology. Partnering with industry leaders like AstraZeneca, Absci blends its AI platform with pharma expertise to accelerate groundbreaking drugs into clinical development. Founder and CEO Sean McClain and Chief Innovation Officer Andreas Busch join For Your Innovation to detail the company's mission and goals. |
Bloomberg's Caroline Hyde discusses Bitc...
As companies navigate a politically char...
Singapore has built one of the world's b...
How would tariffs on imported goods affe...
Should robots be trusted with human live...
Southwest Airlines (LUV) looks to trim w...
----------------------------------------...
「SBI FX NEWS!」原則、毎営業日16時頃配信予定! インターバンクディ...
Student-grade colored pencils and profes...
Nintendo Music is a streaming service fo...
One key area of focus for us has always ...
It's been a Mac-heavy week! In this epis...
Absci is harnessing AI to design drug ca...
Student-grade colored pencils and profes...
Absci is harnessing AI to design drug ca...
Nintendo Music is a streaming service fo...
It's been a Mac-heavy week! In this epis...
One key area of focus for us has always ...